Russia-US nuclear pact is about to end and we won't see another

New START is due to expire on 5 February 2026, leaving for the first time in decades no active treaty limiting US and Russian nuclear arsenals after talks on a replacement have faltered; the US and Russia each hold more than 5,000 warheads while China has roughly 600 and is rapidly expanding. Inspections were suspended after Russia’s 2022 invasion of Ukraine, there is renewed talk of nuclear testing, and experts warn the loss of transparency raises geopolitical risk and could prompt short-term extensions or ad hoc deals but makes long-term arms control unlikely. For investors, heightened geopolitical uncertainty is a clear risk-off catalyst that could lift defense spending expectations and safe-haven assets while increasing volatility across markets.

Analysis

Market structure: Loss of New START structurally favors defense prime contractors (airborne/ICBMs, C4ISR) and nuclear fuel suppliers while pressuring travel/leisure, EM assets and arms-control service providers. Expect a 6–12 month re-rating: defense revenue growth consensus could move from +3% to +6–8% CAGR as governments accelerate procurement; uranium spot tightening could lift prices 30–50% over 12–24 months if inventory draws persist.

Risk assessment: Immediate (days) risk-off will likely push VIX +15–30% and safe-haven flows into USD and gold (GLD) and 2–10yr Treasuries (10y yield down 10–30 bps). Short-term (weeks–months) tail risks include a geopolitical incident or resumed testing triggering commodity/insurance shocks; long-term (years) sees sustained higher defense budgets but also export controls/sanctions fragmenting supply chains.

Trade implications: Tactical plays: overweight LMT, NOC, RTX and uranium exposure (CCJ, URA) while underweight airlines (AAL) and EM cyclical ETFs (EEM) for a 3–12 month horizon. Use options to hedge market dislocations: buy 3-month SPX 5% OTM puts (1–2% notional) and/or VIX call spreads to protect portfolios against 20%+ drawdowns.

Contrarian angles: Consensus assumes continuous escalation — that is underpriced into uranium and overbaked into short-term defense multiples; nuclear testing rhetoric historically blusters more than substance. If a diplomatic band-aid (1-year extension) occurs within 90 days, defense names could pull back 10–20% quickly; conversely, true treaty collapse raises structural winners for several years.

Key Decisions for Investors

• Establish a 3% portfolio long in LMT and 2.5% long in NOC (equal-weight) as a 6–12 month macro hedge to rising defense budgets; trim if either rallies >25% or a treaty extension is announced within 90 days.
• Allocate 2% to uranium exposure: 1.5% CCJ (Cameco) and 0.5% URA (uranium ETF) for a 12–24 month play; add on any >10% pullback in spot uranium or miner equities.
• Purchase 1.5% notional protection via 3‑month SPX 5% OTM puts (staggered in two tranches) plus a 1% notional VIX call spread (buy VXX calls / sell higher strike) to hedge a short-term volatility shock.
• Reduce cyclical travel/tourism exposure by 50% vs benchmark: cut airlines (e.g., AAL) and leisure ETF allocations now and redeploy to defensive segments (defense, gold). Reassess after 60–90 days or upon credible diplomatic thaw.
• Increase short-term duration exposure 2–3% of portfolio into IEF (7–10yr Treasury ETF) to capture flight-to-quality if risk-off intensifies; exit if 10yr yield climbs back >25 bps from current level or inflation-linked signals deteriorate.